Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Revolutionary AI model improves early dementia diagnosis

Revolutionary AI model improves early dementia diagnosis

Accelerate Your Research: Dispen3D Harnesses the Power of 3D Models

Accelerate Your Research: Dispen3D Harnesses the Power of 3D Models

FDA approved PDE4 inhibitor roflumilast for atopic dermatitis

FDA approved PDE4 inhibitor roflumilast for atopic dermatitis

Innovative technique speeds up search for antimicrobial drug candidates

Innovative technique speeds up search for antimicrobial drug candidates

Researchers identify neurons in a small brain region that delay feeding initiation

Researchers identify neurons in a small brain region that delay feeding initiation

60 years in the making: Nanoparticles revolutionize nucleotide delivery

60 years in the making: Nanoparticles revolutionize nucleotide delivery

Newcells Biotech appoints Emile Shaffu as Director of Sales

Newcells Biotech appoints Emile Shaffu as Director of Sales

Case Western Reserve University receives $1.5M grant for oral drug trial to prevent blindness in RP patients

Case Western Reserve University receives $1.5M grant for oral drug trial to prevent blindness in RP patients

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Protein biomarkers in spinal fluid offer promise for early progressive supranuclear palsy diagnosis

Protein biomarkers in spinal fluid offer promise for early progressive supranuclear palsy diagnosis

Pioneering Live Cell Imaging - Yokogawa's Impact and Innovations

Pioneering Live Cell Imaging - Yokogawa's Impact and Innovations

Innovative HIV vaccine approaches yield potential for broad protection against viral strains

Innovative HIV vaccine approaches yield potential for broad protection against viral strains

Modulating gene expression using small molecules

Modulating gene expression using small molecules

Optibrium demonstrates accelerated lead optimization in complex agrochemical development

Optibrium demonstrates accelerated lead optimization in complex agrochemical development

New study reveals key to more effective antihistamines

New study reveals key to more effective antihistamines

Moffitt scientists develop breakthrough method for scalable synthesis of withanolides

Moffitt scientists develop breakthrough method for scalable synthesis of withanolides

New method developed to map mechanistic connections between diseases

New method developed to map mechanistic connections between diseases

Discovery of nanoparticle-based drug delivery system could revolutionize schizophrenia treatment

Discovery of nanoparticle-based drug delivery system could revolutionize schizophrenia treatment

CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team

CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team

ELRIG UK and The Protein Society Partner to advance protein sciences in drug discovery

ELRIG UK and The Protein Society Partner to advance protein sciences in drug discovery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.